Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Oral Clofarabine in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma

NCT00644189 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00644189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00644189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Oral Clofarabine in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2021
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic large-cell lymphoma, angioimmunoblastic t-cell lymphoma, diffuse large b-cell lymphoma, follicular lymphoma, low grade b-cell lymphoma, not otherwise specified, lymphoplasmacytic lymphoma, mantle cell lymphoma, marginal zone lymphoma, peripheral t-cell lymphoma, small lymphocytic lymphoma